Clinical trial
A Prospective, Multicenter Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Autologous and Allogeneic Stem Cell Transplant.
NCT02088840 is registered in ClinicalTrials.gov with Gruppo Italiano Trapianto di Midollo Osseo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Autologous and Allogeneic Stem Cell Transplant.
- Lead sponsor
- Gruppo Italiano Trapianto di Midollo Osseo
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- April 30, 2016
- Enrollment
- 2,769 (actual)
- Sites
- 54
Conditions
As the registry lists them; a condition with its own page is linked.
complications of organ transplant stem cells, gram-negative bacterial infections